Eli Lilly and Ypsome partner to advance automated insulin delivery system

November 20, 2020
Medical Communications

Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …

fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020
Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020
Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

November 20, 2020
Medical Communications

The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …

gilead-sciences

Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1

November 19, 2020
Research and Development Gilead, HIV, pharma

Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …

OPEN Health reveals new CEO appointment

November 19, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …

download

First multiple sclerosis clinical trial for patients who can’t walk to begin recruitment

November 19, 2020
Business Services

The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year.  …

flu_vaccination_grippe_5115654021_3

Five Chinese coronavirus vaccines in overseas clinical trials

November 19, 2020
Business Services

Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world.  The countries conducting the …

1200px-flag_of_vietnam

Vietnam selected as Asian pilot country for UK’s new global healthcare partnership

November 19, 2020
Business Services

A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has …

bristol_myers_squibb_moreton_wirral_-_img_0369

Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia

November 18, 2020
Research and Development

Bristol Myers Squibb has announced that its acquisition of MyoKardia has been completed, with the transaction worth a total of …

lilly_building_with_american_flag_web

NICE recommends Lilly’s Emgality for chronic and episodic migraine

November 18, 2020
Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …

fda_21_4_1_0

FDA approves first at-home coronavirus self-testing kit

November 18, 2020
Research and Development

The FDA has issued an Emergency Use Authorization for the first coronavirus self-testing kit for use at home that produces …

vaccination-1215279_960_720

Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s

November 18, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 18, 2020
Research and Development

The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created …

AstraZeneca’s Brilinta reduces stroke and death risk in head and neck artery atherosclerosis patients

November 17, 2020
Manufacturing and Production

AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had …

dr_reddys_chairman_satish

Pfizer takes legal action against Indian drugmakers over generic cancer drug

November 17, 2020
Manufacturing and Production

Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges …

shutterstock_159488225

Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn

November 17, 2020
Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …

pfizer_finland_hq_february_13_2009

Pfizer launches pilot delivery programme for its coronavirus vaccine

November 17, 2020
Manufacturing and Production

Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be …

moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …

512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor UÄŸur Åžahin, Professor …

The Gateway to Local Adoption Series

Latest content